Viking Files Registration Statement with SEC for Proposed Initial Public OfferingPRNewsWire • 04/05/24
Better Booming Biotech Stock: Madrigal Pharmaceuticals vs. Viking TherapeuticsThe Motley Fool • 04/05/24
Could This 1 Detail Help Viking Therapeutics Top Eli Lilly and Novo Nordisk in the Weight Loss Drug Market?The Motley Fool • 04/04/24
Viking Therapeutics Stock Has 72% Upside, According to 1 Wall Street AnalystThe Motley Fool • 04/01/24
Why Eli Lilly And Rival Novo Nordisk Won't Be Troubled By Viking's Latest Weight Loss DataSeeking Alpha • 03/31/24